Cullinan Therapeutics, Inc. (CGEM) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Cullinan Therapeutics, Inc. (CGEM) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

CGEM Income Statement

Cullinan Therapeutics, Inc. (CGEM) annual income statement — 8-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-100%	-	-
Cost of Goods Sold	0	0	0	0	0	0	0	0	77K	76K	77K	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	-77K	-76K	-77K	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	100%	100%	100%	-	-	-	-	-	-	-	-	-	-	-100%	-	-
Operating Expenses	57.25M	53.7M	55.26M	55.59M	75.8M	55M	55.05M	48.85M	49.95M	42.91M	45.41M	45.24M	37.6M	62.76M	32.61M	29.77M	-239.68M	32.66M	34.35M	18.38M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	12.82M	11.57M	12.31M	13.63M	14.77M	13.54M	14.56M	13.35M	13.69M	12.27M	10.56M	10.98M	10.21M	10.66M	11.29M	10.09M	10.7M	8.12M	13.47M	5.7M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	44.44M	42.12M	42.95M	41.97M	61.03M	41.46M	40.49M	35.51M	36.26M	30.65M	34.85M	33.82M	27.39M	52.1M	21.32M	19.68M	26.41M	24.54M	20.88M	12.68M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	440K	0	0	0	0	-1000K	0	0	0
Operating Income	-57.25M	-53.7M	-55.26M	-55.59M	-75.8M	-55M	-55.05M	-48.85M	-50.03M	-42.99M	-45.48M	-45.24M	-37.6M	-62.76M	-32.61M	-29.77M	239.68M	-32.66M	-34.35M	-18.38M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	24.46%	2.36%	-0.38%	-13.8%	-51.51%	-27.93%	-21.02%	-7.98%	-33.03%	31.5%	-39.49%	-52%	-115.69%	-92.17%	5.06%	-61.99%	1543.5%	-2480.25%	-17.74%	-59.8%
EBITDA	-57.17M	-53.62M	-55.18M	-55.52M	-75.72M	-54.92M	-54.97M	-48.78M	-49.95M	-42.91M	-45.41M	-45.16M	-37.52M	-62.68M	-32.55M	-29.76M	239.69M	-32.64M	-34.34M	-18.36M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	24.49%	2.37%	-0.38%	-13.81%	-51.59%	-27.98%	-21.06%	-8.01%	-33.11%	31.54%	-39.51%	-51.77%	-115.66%	-92.02%	5.2%	-62.06%	1544.71%	-2453.57%	-17.76%	-59.89%
D&A (Non-Cash Add-back)	79K	79K	79K	79K	77K	76K	77K	76K	77K	76K	77K	80K	81K	72K	59K	9K	12K	13K	12K	13K
EBIT	-53.7M	-53.7M	-50.71M	-50.61M	-70.06M	-48.5M	-47.53M	-40.56M	-42.03M	-37.34M	-45.48M	-44.8M	-37.6M	-62.76M	-32.61M	-29.77M	-37.11M	-32.66M	-34.35M	-18.38M
Net Interest Income	3.65M	4.1M	4.62M	5.09M	5.92M	6.58M	7.51M	8.38M	8.07M	5.69M	5.92M	5.88M	5.32M	4.51M	3.36M	2.35M	697K	197K	137K	118K
Interest Income	3.65M	4.1M	4.62M	5.09M	5.92M	6.58M	7.51M	8.38M	8.07M	5.69M	5.92M	5.88M	5.32M	4.51M	3.36M	2.35M	697K	197K	137K	118K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	3.55M	4.04M	4.55M	4.99M	5.74M	6.5M	7.52M	8.29M	8M	5.65M	5.8M	6.06M	5.39M	4.62M	3.66M	2.35M	456K	197K	141K	116K
Pretax Income	-53.7M	-49.66M	-50.71M	-50.61M	-70.06M	-48.5M	-47.53M	-40.56M	-42.03M	-37.34M	-39.69M	-39.18M	-32.21M	-58.14M	-28.95M	-27.41M	240.13M	-32.46M	-34.21M	-18.26M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	117K	0	0	0	-14.12M	0	0	0	-1.86M	-2.52M	66.07M	-19.57M	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	-0.25%	0%	0%	0%	35.59%	0%	0%	0%	6.42%	9.2%	27.51%	60.28%	0%	0%
Net Income	-53.7M	-49.66M	-50.71M	-50.61M	-70.06M	-48.5M	-47.65M	-40.56M	-42.03M	-37.15M	-23.8M	-39.18M	-32.21M	-57.96M	-26.78M	-24.8M	174.9M	-12.1M	-32.51M	-17.35M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	23.34%	-2.39%	-6.43%	-24.78%	-66.69%	-30.56%	-100.17%	-3.51%	-30.46%	35.91%	11.12%	-57.97%	-118.42%	-379.1%	17.63%	-42.96%	1218.56%	-17182.86%	-14.7%	-76%
Net Income (Continuing)	-53.7M	-49.66M	-50.71M	-50.61M	-70.06M	-48.5M	-47.65M	-40.56M	-42.03M	-37.34M	-25.56M	-39.18M	-32.21M	-58.14M	-27.09M	-24.89M	174.06M	-12.89M	-34.21M	-18.26M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	192K	0	0	0	0	0	80K	768K	403K	2.09M
EPS (Diluted)	-0.81	-0.84	-0.86	-0.86	-1.19	-0.82	-0.81	-0.70	-0.76	-0.86	-0.56	-0.92	-0.81	-1.42	-0.59	-0.54	3.77	-0.27	-0.74	-0.40
EPS Growth %	31.93%	-2.44%	-6.17%	-22.86%	-56.58%	4.65%	-44.64%	23.91%	6.17%	39.44%	5.08%	-70.37%	-121.49%	-425.93%	20.27%	-35%	1147.22%	-	-8.82%	-53.85%
EPS (Basic)	-0.81	-0.84	-0.86	-0.86	-1.19	-0.82	-0.81	-0.70	-0.76	-0.86	-0.56	-0.92	-0.81	-1.42	-0.59	-0.54	3.90	-0.27	-0.74	-0.40
Diluted Shares Outstanding	61.49M	59.2M	59.2M	59.02M	59.02M	58.91M	58.58M	58.34M	55.05M	43.01M	42.79M	42.73M	39.95M	40.68M	45.75M	45.61M	46.38M	44.43M	43.64M	43.44M
Basic Shares Outstanding	61.49M	59.2M	59.2M	59.02M	59.02M	58.91M	58.58M	58.34M	55.05M	43.01M	42.79M	42.73M	39.95M	40.68M	45.75M	45.61M	44.87M	44.43M	43.52M	43.44M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-